About
A steady increase in the prevalence of allergic diseases globally has occurred with about 30-40% of the world population now being affected by one or more allergic conditions. Modern healthcare bodies and authorities agree that they cannot cure an allergy, but can only treat the symptoms by either avoiding the allergen, taking medications (Antihistamines and Steroids, epinephrine (EpiPen)), or getting into a long-lasting treatment process of 2-4 years, called Immunotherapy. We are developing a digital personalized healthcare therapy that will revolutionize the global allergy industry and the a/m concept by offering a nonintrusive solution that leverages decades of impactful alternative medicine therapies and techniques to overcome allergies. Our solution utilizes advanced algorithms that analyze patients' physiological parameters to autonomously administer a proprietary therapeutic protocol that by accessing the subconscious mind retrains the immune system to avoid, or reduce, allergy inflammation for a long period, which means developing resilience to the disease and prevent allergy symptoms for an extended period. Our methodology is firmly rooted in the modern holistic healthcare paradigm, which seamlessly integrates conventional medicine with complementary and alternative practices. The treatment, a quick 20- to 30-minute session, can be seamlessly integrated into mainstream healthcare or employed as a standalone therapy. Drawing inspiration from the scientific field of psychoneuroimmunology, our treatments address each patient's mental state and mindset. Pimea AI is committed to ushering in a new era of allergy relief that prioritizes individual well-being and long-term health.
Q&A
- What is Pimea AI's primary focus?
- Pimea AI is developing a digital personalized healthcare therapy for allergies that aims to retrain the immune system to reduce or avoid allergy inflammation by accessing the subconscious mind.
- When was Pimea AI founded?
- Pimea AI was founded in June 2022.
- What is Pimea AI's current funding stage?
- Pimea AI is currently in the Pre-Funding stage.
- What sector does Pimea AI operate in?
- Pimea AI operates in the Health Tech & Life Sciences sector, with additional focus on Digital Healthcare, Digital Therapeutics, Medical Devices, and Medical Treatment & Therapeutics.
- What technologies does Pimea AI utilize in its solution?
- Pimea AI utilizes technologies such as Sensing, Platforms & Interfaces, Software, and Artificial Intelligence.
- Who is the founder and CEO of Pimea AI?
- The founder and CEO of Pimea AI is Omer Hevlin.
- What is the core methodology behind Pimea AI's treatment?
- Pimea AI's methodology is rooted in the modern holistic healthcare paradigm, integrating conventional medicine with complementary and alternative practices, and drawing inspiration from psychoneuroimmunology to address patients' mental states and mindsets.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | pimea-ai.com/ |
|---|
Identifiers & details
| Founded | 2022-6 |
|---|---|
| Employees (exact) | 3 |
Radar intelligence
Web history (Wayback)
| Domain | pimea-ai.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|